EL7.AI
StocksMedium•17 November 2026•
1 min read

Predictive Oncology Beats Q3 EPS Estimates Despite Revenue Miss

Key Facts

1Predictive Oncology reported GAAP EPS of $0.52, beating estimates by $0.81.
2The company's revenue reached $7.24M, missing analyst estimates by $2.06M.

Predictive Oncology reported GAAP earnings per share of $0.52 for the third quarter of 2026. Seeking Alpha reported that these results beat analyst estimates by $0.81, reflecting a significant outperformance in profitability relative to initial expectations.

The company's revenue reached $7.24 million during the period, missing analyst estimates by $2.06 million. This divergence between earnings growth and top-line pressure highlights challenges in the company's overall financial performance.